Long-acting injectable antipsychotics: evidence of effectiveness and use.

Canadian journal of psychiatry. Revue canadienne de psychiatrie

Volumn 58, Issue 5 Suppl 1, 2013, Pages

  Manchanda, Rahul ^a   Chue, Pierre ^b   Malla, Ashok ^b   Tibbo, Phil ^b   Roy, Marc André ^b   Williams, Richard ^b   Iyer, Srividya ^b   Lutgens, Danyael ^b   Banks, Nicola ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PALIPERIDONE;

ADHERENCE; CLASSIFICATION; COMMUNITY TREATMENT ORDER; COMPARATIVE EFFECTIVENESS; DELAYED RELEASE FORMULATION; DEPOT; FIRST-EPISODE PSYCHOSIS; HOSPITALIZATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LONG-ACTING INJECTABLE; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; METHODOLOGY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; RISPERIDONE MICROSPHERES; SCHIZOPHRENIA; SECOND-GENERATION ANTIPSYCHOTIC; TREATMENT OUTCOME;

ADHERENCE; COMMUNITY TREATMENT ORDER; DEPOT; FIRST-EPISODE PSYCHOSIS; HOSPITALIZATION; LONG-ACTING INJECTABLE; PALIPERIDONE PALMITATE; RELAPSE; REMISSION; RISPERIDONE MICROSPHERES; SCHIZOPHRENIA; SECOND-GENERATION ANTIPSYCHOTIC;

ADMINISTRATION, ORAL; ANTIPSYCHOTIC AGENTS; COMPARATIVE EFFECTIVENESS RESEARCH; DELAYED-ACTION PREPARATIONS; HOSPITALIZATION; HUMANS; INJECTIONS, INTRAMUSCULAR; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; REMISSION INDUCTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84884344956     PISSN: 07067437     EISSN: None     Source Type: None    
DOI: 10.1177/088740341305805s02     Document Type: Review

References (0)